Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 5Thoracic 2Dermatologic 2Breast 2NET 1Head & Neck 1Gastrointestinal 1Endocrine 1

Conditions

Squamous Cell Carcinoma of Head and Neck 389Head and Neck Neoplasms 340Carcinoma, Non-Small-Cell Lung 230Melanoma 155Colorectal Neoplasms 152Breast Neoplasms 138Ovarian Neoplasms 125Neoplasms 103Stomach Neoplasms 101Carcinoma, Renal Cell 101Neoplasm Metastasis 94Pancreatic Neoplasms 93Lung Neoplasms 87Uterine Cervical Neoplasms 81Triple Negative Breast Neoplasms 75Esophageal Neoplasms 75Prostatic Neoplasms 70Urinary Bladder Neoplasms 69Thyroid Neoplasms 62Carcinoma, Squamous Cell 57Carcinoma, Hepatocellular 57Sarcoma 54Endometrial Neoplasms 54Carcinoma, Transitional Cell 54Small Cell Lung Carcinoma 50Salivary Gland Neoplasms 49Colonic Neoplasms 41Nasopharyngeal Carcinoma 38Mouth Neoplasms 37Kidney Neoplasms 34

Interventions

atezolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Urologic Diseases × Head & Neck × Clear all
NCT02543645 2018-04-30

A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancer

Celldex Therapeutics

Phase 1 Terminated
18 enrolled
BreastDermatologicGenitourinaryHead & NeckThoracic

Clear-cell metastatic renal cell carcinoma, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Head and Neck Neoplasms, Kidney Diseases, Kidney Neoplasms, Melanoma, Neoplasms, Neoplasms by Histologic Type, Urogenital Neoplasms, Urologic Diseases, Urologic Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡